Glycopyrrolate + Formoterol Suppliers & Bulk Manufacturers
Available Forms: Pressurized metered-dose inhaler (pMDI)
Available Strengths: Glycopyrrolate 9 mcg + Formoterol fumarate 4.8 mcg
Reference Brands: Bevespi Aerosphere(US)
Category: Respiratory Disorder
Glycopyrrolate + Formoterol is available in Pressurized metered-dose inhaler (pMDI) and strengths such as Glycopyrrolate 9 mcg + Formoterol fumarate 4.8 mcg. Sourced from GMP-certified and ISO-compliant manufacturers, this API meets global pharmacopeia standards (USP/EP/JP as applicable). Ideal for pharmaceutical formulation and commercial manufacturing, Glycopyrrolate + Formoterol is supplied in bulk quantities with complete regulatory support including DMF, COA, and MSDS.
| Technical Specifications & Supply Details | |
|---|---|
| Lead Time | 7 to 60 days (depending on batch size & schedule) |
| MOQ | As per manufacturer’s batch size |
| COA | Available with every batch |
| Regulatory Dossier / DMF | Available upon request |
| Export Documentation | FSC, COA, Manufacturing License, Product Permission |
| Standards | IP, BP, USP |
| Certifications | WHO-GMP, EU-GMP, USFDA (as applicable) |
Glycopyrrolate + Formoterol can be exported to over 30 countries across Asia, Africa, Europe, and Latin America. Flexible packaging, competitive pricing, and a verified supplier network make Pharmatradz a trusted sourcing partner for pharmaceutical companies and contract manufacturers worldwide.
The Trade Mark owner has been correctly identified under the heading Manufacturer / TM Owner as required by the Act.
Product Description:
Glycopyrrolate + Formoterol is a long-acting bronchodilator combination used for the maintenance treatment of chronic obstructive pulmonary disease (COPD). Glycopyrrolate, a LAMA, and Formoterol, a LABA, work together to relax airway muscles, improve airflow, and reduce symptoms like breathlessness. Marketed as Bevespi Aerosphere in the United States, this combination is delivered via a pressurized metered-dose inhaler (pMDI) and taken twice daily. It is not intended for acute symptom relief but provides long-term control of COPD symptoms. Bevespi Aerosphere helps enhance lung function, reduce exacerbations, and improve the overall quality of life for patients with moderate to severe COPD.
Frequently Asked Questions
Related Products
Fluticasone Furoate + Vilanterol
Strength:
92 mcg Fluticasone furoate / 22 mcg Vilanterol; 184 mcg Fluticasone furoate / 22 mcg Vilanterol
Form: Powder For Inhalation(DPI/MDI)
Reference Brands: Breo Ellipta®(US), Relvar Ellipta® (EU)
View Details
Mometasone + Formoterol
Strength:
100 mcg/5 mcg , 200 mcg/5 mcg
Form: Inhaler(MDI)
Reference Brands: Dulera®(US)
View Details
Ambroxol Hydrochloride
Strength:
Tab: 30 mg, 60 mg; Syrup: 15 mg/5 mL, 30 mg/5 mL; Drops: 7.5 mg/mL, 15 mg/mL
Form: Tablets, Syrup & Oral drops
Reference Brands: Mucosolvan®, Flavamed®, Ambrobeta®, Ambroxol-ratiopharm®(EU)
View Details
Carbocisteine
Strength:
Cap: 375 mg and 750 mg; Oral Solution: 50 mg/5 mL and 750 mg/5 mL
Form: Capsules, Oral Solutions/Syrups
Reference Brands: Mucodyne, Lisomucil®, Rhinathiol®, Muciclar®, Actithiol®, Mucolex®(US)
View DetailsQuick Response Guaranteed | Verified Suppliers
